Connect Biopharma has reported 52-week improvements across multiple endpoints in a phase 3 trial of its eczema drug candidate, fueling the biotech’s belief that its molecule is ...

Gov. Gavin Newsom is trying to rein in runaway costs for the Subsequent Injuries Benefits Trust Fund, which faces liabilities ...

A healthy skin is not only a matter of appearance becuase itchy and inflamed skin may impact sleep, mood and overall ...

The pollen is back – but that doesn't mean you should stop running. We explain the symptoms of hay fever and how to relieve ...

Rademikibart achieved rapid, durable efficacy results across all key endpoints through 52 weeks, with near‑maximal responses achieved in ~90% ...

Although babies born from parents with allergies are also more likely to have them, there are a number of outside factors ...

The $39.99 flat-fee telehealth is now available as a free download on the App Store & Google Play, bringing 24/7 ...

Plenty of lifestyle and health factors can put you on a fast track to osteoporosis.

Will rain provide any relief from this already rough allergy season in the US? Here’s what experts say - Record heat and ...

Enveda, a clinical-stage biotech company developing first-in-class small-molecules derived from life’s chemistry, today ...

SINGAPORE: Clinics around Singapore are reporting a rise in haze-related cases, with some seeing patient numbers climb by up ...